Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-AMino-1-(4-fluorophenyl)propan-1-ol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

254967-36-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 254967-36-7 Structure
  • Basic information

    1. Product Name: 3-AMino-1-(4-fluorophenyl)propan-1-ol
    2. Synonyms: 3-AMino-1-(4-fluorophenyl)propan-1-ol
    3. CAS NO:254967-36-7
    4. Molecular Formula: C9H12FNO
    5. Molecular Weight: 169.1960832
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 254967-36-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 296.8°C at 760 mmHg
    3. Flash Point: 133.3°C
    4. Appearance: /
    5. Density: 1.167g/cm3
    6. Vapor Pressure: 0.000631mmHg at 25°C
    7. Refractive Index: 1.54
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. CAS DataBase Reference: 3-AMino-1-(4-fluorophenyl)propan-1-ol(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-AMino-1-(4-fluorophenyl)propan-1-ol(254967-36-7)
    12. EPA Substance Registry System: 3-AMino-1-(4-fluorophenyl)propan-1-ol(254967-36-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 254967-36-7(Hazardous Substances Data)

254967-36-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 254967-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,4,9,6 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 254967-36:
(8*2)+(7*5)+(6*4)+(5*9)+(4*6)+(3*7)+(2*3)+(1*6)=177
177 % 10 = 7
So 254967-36-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H12FNO/c10-8-3-1-7(2-4-8)9(12)5-6-11/h1-4,9,12H,5-6,11H2

254967-36-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-amino-1-(4-fluorophenyl)propan-1-ol

1.2 Other means of identification

Product number -
Other names F2189-0747

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:254967-36-7 SDS

254967-36-7Downstream Products

254967-36-7Relevant articles and documents

AMINOTRIAZOLOPYRIDINES AS KINASE INHIBITORS

-

Page/Page column 145, (2018/09/08)

Compounds having formula (I) (IX), and enantiomers, and diastereomers, stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein: (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).

Novel compound capable of activating Nrf2, and pharmaceutical compositions comprising the same

-

Paragraph 1069; 1118-1120, (2016/10/08)

The present invention provides a novel compound which can activate Nrf2 that is a transcription factor for expression of the quinone reductase gene. Therefore the compound is effective for inhibiting apoptosis and preventing and treating brain nerve disea

A modular lead-oriented synthesis of diverse piperazine, 1,4-diazepane and 1,5-diazocane scaffolds

James, Thomas,Maclellan, Paul,Burslem, George M.,Simpson, Iain,Grant, J. Andrew,Warriner, Stuart,Sridharan, Visuvanathar,Nelson, Adam

supporting information, p. 2584 - 2591 (2014/04/17)

Piperazines are found widely in commercially-available compounds and bioactive molecules (including many drugs). However, in the vast majority of these molecules, the piperazine ring is isolated (i.e. not fused to another ring) and is not substituted on any of its carbon atoms. A modular synthetic approach is described in which combinations of cyclic sulfamidate and hydroxy sulfonamide building blocks may be converted into piperazines and related 1,4-diazepine and 1,5-diazocane scaffolds. By variation of the combinations of building blocks used, it was possible to vary the ring size, substitution and configuration of the resulting heterocyclic scaffolds. The approach was exemplified in the synthesis of a range of heterocyclic scaffolds that, on decoration, would target lead-like chemical space. It was demonstrated that lead-like small molecules based on these scaffolds would likely complement those found in large compound collections. This journal is the Partner Organisations 2014.

Synthesis and Nrf2 activating ability of thiourea and vinyl sulfoxide derivatives

Shim, Young Sun,Hwang, Hyun Sook,Nam, Ghilsoo,Choi, Kyung Il

, p. 2317 - 2320 (2013/09/24)

Thiourea and vinyl sulfoxide derivatives were designed based on the structures of sulforaphane and gallic acid, prepared and tested for HO-1 inducing activity as a measure of Nrf2 activation, and inhibitory effect on NO production as a measure of anti-inf

Polymer-supported chiral sulfonamide catalyzed one-pot reduction of β-keto nitriles: A practical synthesis of (R)-fluoxetine and (R)-duloxetine

Wang, Guangyin,Liu, Xingshun,Zhao, Gang

, p. 1873 - 1879 (2007/10/03)

Enantioselective reduction of β-keto nitriles to optically active 1,3-amino alcohols has been carried out in one step using an excess of borane-dimethyl sulfide complex as a reductant and a polymer-supported chiral sulfonamide as a catalyst with moderate to high enantioselectivity. The facile and enantioselective method to prepare optically active 1,3-amino alcohols to be converted into 3-aryloxy-3-arylpropylamine-type antidepressant drugs (R)-fluoxetine, and (R)-duloxetine is also reported.

Aminoalcohols and aminoketones as CNS active agents

-

, (2008/06/13)

The present application relates to aminoalcohols and ketoamines of general formula I and to pharmaceutically acceptable salts and esters thereof, which interact with CNS receptors and can be used as drugs for the treatment of CNS diseases or, if opportune

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 254967-36-7